Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2022	Jun. 30, 2021
Current assets
Cash and cash equivalents	$ 241	$ 319
Receivables, net	660	604
Inventories, net	803	752
Prepaid expenses and other current assets	165	154
Total current assets	1,869	1,829
Property, plant and equipment, net of accumulated depreciation and amortization of $2,510 and $2,382, respectively	1,312	1,302
Operating lease right-of-use assets	311	332
Goodwill	1,572	1,575
Trademarks, net	690	693
Other intangible assets, net	204	225
Other assets	364	378
Total assets	6,322	6,334
Current liabilities
Notes and loans payable	395	0
Current maturities of long-term debt	600	300
Current operating lease liabilities	73	81
Accounts payable and accrued liabilities	1,575	1,675
Total current liabilities	2,643	2,056
Long-term debt	1,887	2,484
Long-term operating lease liabilities	288	301
Other liabilities	843	834
Deferred income taxes	85	67
Total liabilities	5,746	5,742
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2022 and June 30, 2021; and 123,071,356 and 122,780,220 shares outstanding as of March 31, 2022 and June 30, 2021, respectively	131	131
Additional paid-in capital	1,195	1,186
Retained earnings	951	1,036
Treasury stock, at cost: 7,670,105 and 7,961,241 shares as of March 31, 2022 and June 30, 2021, respectively	(1,358)	(1,396)
Accumulated other comprehensive net (loss) income	(519)	(546)
Total Clorox stockholders’ equity	400	411
Noncontrolling interests	176	181
Total stockholders’ equity	576	592
Total liabilities and stockholders’ equity	$ 6,322	$ 6,334